p73 haploinsufficiency causes tau hyperphosphorylation and tau kinase dysregulation in mouse models of aging and Alzheimer's disease

被引:23
|
作者
Cancino, Gonzalo I. [1 ,2 ]
Miller, Freda D. [2 ,3 ,4 ]
Kaplan, David R. [1 ,3 ]
机构
[1] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1L7, Canada
[2] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada
[3] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada
[4] Univ Toronto, Dept Physiol, Toronto, ON, Canada
关键词
p73; p53; family; Tau phosphorylation; Pin1; Alzheimer's disease; Aging; Neurodegeneration; GSK-3; beta; c-Abl; Cdk5; Tauopathy; Paired helical filaments; TgCRND8; PROLYL ISOMERASE PIN1; C-ABL; NEURONAL SURVIVAL; P53; FAMILY; PHOSPHORYLATION; CDK5; MAINTENANCE; PATHOLOGY; BRAIN; MICE;
D O I
10.1016/j.neurobiolaging.2012.04.010
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Haploinsufficiency for the p53 family member p73 causes behavioral and neuroanatomical correlates of neurodegeneration in aging mice, including the appearance of aberrant phospho-tau-positive aggregates. Here, we show that these aggregates and tau hyperphosphorylation, as well as a generalized dysregulation of the tau kinases GSK3 beta, c-Abl, and Cdk5, occur in the brains of aged p73+/- mice. To investigate whether p73 haploinsufficiency therefore represents a general risk factor for tau hyperphosphorylation during neurodegeneration, we crossed the p73+/- mice with 2 mouse models of neurodegeneration, TgCRND8+/empty set mice that express human mutant amyloid precursor protein, and Pin1-/- mice. We show that haploinsufficiency for p73 leads to the early appearance of phospho-tau-positive aggregates, tau hyperphosphorylation, and activation of GSK3 beta, c-Abl, and Cdk5 in the brains of both of these mouse models. Moreover, p73+/-; TgCRND8+/empty set mice display a shortened lifespan relative to TgCRND8+/empty set mice that are wild type for p73. Thus, p73 is required to protect the murine brain from tau hyperphosphorylation during aging and degeneration. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:387 / 399
页数:13
相关论文
共 50 条
  • [1] Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease
    Li, Shu-Qin
    Yu, Yang
    Han, Jin-Zhao
    Wang, Ding
    Liu, Jin
    Qian, Feng
    Fan, Guo-Huang
    Bucala, Richard
    Ye, Richard D.
    JOURNAL OF NEUROINFLAMMATION, 2015, 12
  • [2] Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer's disease transgenic mouse
    Zhao, Haikang
    Chang, Rui
    Che, Haijiang
    Wang, Jianbang
    Yang, Lei
    Fang, Wei
    Xia, Yi
    Li, Nan
    Ma, Quanrui
    Wang, Xuelian
    NEUROSCIENCE LETTERS, 2013, 551 : 12 - 16
  • [3] Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease
    Gratuze, Maud
    Noel, Anastasia
    Julien, Carl
    Cisbani, Giulia
    Milot-Rousseau, Philippe
    Morin, Francoise
    Dickler, Maya
    Goupil, Claudia
    Bezeau, Francois
    Poitras, Isabelle
    Bissonnette, Stephanie
    Whittington, Robert A.
    Hebert, Sebastien S.
    Cicchetti, Francesca
    Parker, J. Alex
    Samadi, Pershia
    Planel, Emmanuel
    HUMAN MOLECULAR GENETICS, 2015, 24 (01) : 86 - 99
  • [4] Distribution of tau hyperphosphorylation in canine dementia resembles early Alzheimer's disease and other tauopathies
    Abey, Ajantha
    Davies, Danielle
    Goldsbury, Claire
    Buckland, Michael
    Valenzuela, Michael
    Duncan, Thomas
    BRAIN PATHOLOGY, 2021, 31 (01) : 144 - 162
  • [5] A Caenorhabditis elegans model of tau hyperphosphorylation: Induction of developmental defects by transgenic overexpression of Alzheimer's disease-like modified tau
    Brandt, Roland
    Gergou, Aikaterini
    Wacker, Irene
    Fath, Thomas
    Hutter, Harald
    NEUROBIOLOGY OF AGING, 2009, 30 (01) : 22 - 33
  • [6] JNK Plays a Key Role in Tau Hyperphosphorylation in Alzheimer's Disease Models
    Ploia, Cristina
    Antoniou, Xanthi
    Sclipa, Alessandra
    Grande, Valentina
    Cardinetti, Daniele
    Colombo, Alessio
    Canu, Nadia
    Benussi, Luisa
    Ghidoni, Roberta
    Forloni, Gianluigi
    Borsello, Tiziana
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 26 (02) : 315 - 329
  • [7] GSK-3β dysregulation in aging: Implications for tau pathology and Alzheimer's disease progression
    Rekha, A.
    Afzal, Muhammad
    Babu, M. Arockia
    Menon, Soumya, V
    Nathiya, Deepak
    Supriya, S.
    Mishra, Shakti Bedanta
    Gupta, Sofia
    Goyal, Kavita
    Rana, Mohit
    Ali, Haider
    Imran, Mohd
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2025, 133
  • [8] Starvation induces tau hyperphosphorylation in mouse brain: implications for Alzheimer's disease
    Yanagisawa, M
    Planel, E
    Ishiguro, K
    Fujita, SC
    FEBS LETTERS, 1999, 461 (03) : 329 - 333
  • [9] Effect of p62 on tau hyperphosphorylation in a rat model of Alzheimer's disease
    Zheng, Xianhong
    Wang, Weiwei
    Liu, Ruizhi
    Huang, Honglan
    Zhang, Rihui
    Sun, Liankun
    NEURAL REGENERATION RESEARCH, 2012, 7 (17) : 1304 - 1311
  • [10] Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease
    Liu, F
    Zaidi, T
    Iqbal, K
    Grundke-Iqbal, I
    Merkle, RK
    Gong, CX
    FEBS LETTERS, 2002, 512 (1-3) : 101 - 106